Which are the causes of Ehlers Danlos?

Ehlers-Danlos syndromes (EDS) are a group of heritable connective tissue disorders primarily caused by genetic mutations that disrupt the production, structure, or processing of collagen, the protein responsible for providing strength and elasticity to tissues throughout the body.

The Genetic Basis of Ehlers-Danlos

Think of collagen as the "glue" that holds your body together; in individuals with Ehlers-Danlos, this glue is either produced in insufficient quantities or is structurally flawed, leading to tissues that are fragile and overly flexible. Most forms of Ehlers-Danlos are inherited in an autosomal dominant pattern, meaning a child has a 50% chance of inheriting the mutation from an affected parent. Mutations have been identified in several genes, such as COL5A1 and COL5A2 in the Classical type, or COL3A1 in the Vascular type. While the genetic cause for the most common form, Hypermobile Ehlers-Danlos, remains elusive and has not yet been definitively mapped to a single gene, researchers are actively using whole-genome sequencing to identify the underlying molecular culprits.

Causes vs. Risk Factors

It is important to distinguish between the primary cause—the genetic mutation—and environmental risk factors. Ehlers-Danlos is strictly genetic; you cannot "catch" it from an infection or develop it due to environmental triggers. However, secondary factors, such as physical trauma or hormonal shifts, can act as risk factors that exacerbate symptoms or trigger the onset of clinical complications in someone who already carries the genetic predisposition for Ehlers-Danlos. There is no evidence that autoimmune or metabolic processes cause the disease, though they may occasionally coexist as separate conditions.

Current Research

Because the molecular mechanism of the hypermobile type is still being investigated, current research is focused on multi-omics approaches—studying the interaction between genes, proteins, and metabolites—to better understand the etiology of the syndrome. By mapping these complex biological pathways, scientists hope to move toward more precise diagnostics and targeted therapies for the community.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• The Ehlers-Danlos Society


• Online Mendelian Inheritance in Man (OMIM)